Purchase Order HT940626PE011

The Defense Health Agency awarded a $1.54M firm fixed-price purchase order to Biofire Defense LLC on April 15, 2025, for the procurement of a molecular assay analyzer with an ultimate completion date of April 14, 2026. The equipment will be delivered to Camp Pendleton North, California. Biofire Defense, a Salt Lake City-based manufacturer of molecular diagnostic technologies, specializes in rapid pathogen identification systems and has been an established federal contractor since 2001. This...

The Defense Health Agency (DHA) awarded a $5.42 million firm fixed-price purchase order to Biofire Defense LLC for molecular infectious disease polymerase chain reaction (PCR) testing services, effective October 1, 2025, through September 30, 2026, with an ultimate completion date of September 30, 2030. This non-set-aside contract represents DHA's continued investment in advanced diagnostic capabilities for infectious disease detection and biodefense applications. Biofire Defense, a Salt Lake...

The Defense Health Agency (DHA) awarded a $3.5 million firm fixed-price purchase order to Biofire Defense LLC on September 30, 2024, for molecular diagnostic kits with a completion date of September 29, 2029. This contract, which includes no set-aside designation, will be performed in Bethesda, Maryland. Biofire Defense is a specialized manufacturer of biological agent identification and molecular diagnostic solutions based in Salt Lake City, Utah, known for its FilmArray and RAZOR Mk II systems...

The Naval Medical Research Command, on behalf of the Bureau of Medicine and Surgery, issued a purchase order to Biofire Defense LLC on June 1, 2025, for biofire diagnostic assay test panels with a ceiling value of $195,034.32. The order procures supplies for Global Fever Special Pathogens Panel, Warrior Panel, and Respiratory Panel assay testing under firm fixed-price commercial item terms. Place of performance is Silver Spring, Maryland. The ultimate completion date is March 1, 2028. The...

This is a firm fixed price purchase order contract awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for $632,736.78 to provide a respiratory panel for the Walter Reed National Military Medical Center, with a period of performance through May 25, 2024. The contract has no set-aside designation. Biofire Defense has previously received other federal contracts and grants...

The U.S. Marine Corps awarded a $16.5K firm fixed-price purchase order to Biofire Defense LLC on March 25, 2026, for BioFire diagnostic panels with an ultimate completion date of April 10, 2026. The award was issued with no set-aside designation to the Salt Lake City-based manufacturer of molecular diagnostic technologies and biological agent identification products. Biofire Defense specializes in rapid pathogen identification systems, leveraging its core product portfolio including FilmArray...

The Defense Health Agency awarded Biofire Defense LLC a delivery order valued at $968.3K for an equipment lease contract covering two multiplex molecular analyzer systems and testing panel reagents for Madigan Army Medical Center's Department of Pathology in Tacoma, Washington. The contract runs through September 30, 2026, and was awarded on October 1, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued under a larger $4.85M Indefinite Delivery...

The Defense Health Agency awarded a $288,915 firm fixed-price delivery order to Biofire Defense LLC on October 1, 2025, for BioFire Torch maintenance services at the contractor's San Diego, California facility. This delivery order, subject to availability of funds per Federal Acquisition Regulation clause 52.232-18, is scheduled for completion by September 30, 2030, and was issued under a larger $4.85 million Indefinite Delivery Contract established between the Defense Health Agency and...

The Bureau of Medicine and Surgery awarded a $18,034 firm fixed-price purchase order to Biofire Defense LLC on December 3, 2024, for the BIOFIRE DEFENSE PRODUCT NGDS-ASY-0017. The contract, which requires completion by February 28, 2025, will be performed in Frederick, Maryland. This purchase order represents a tactical procurement from Biofire Defense, a Salt Lake City-based manufacturer specializing in molecular diagnostic technologies and biological agent identification products. No set-aside...

This is a firm-fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Biofire Defense LLC, a large business manufacturer of goods, for the procurement of 2 FilmArray 2.0 complete configuration systems with laptops. The contract has a ceiling value of $79,522.00 and a period of performance ending on July 31, 2018. Biofire Defense has previously been awarded federal contracts and grants related to biological agent identification products, COVID-19 testing,...